A cutting-edge genetic test can rapidly detect and identify almost any kind of disease-causing microorganism ... Both the ...

A new study led by Genomics England and Queen Mary University of London estimates that genetic testing could identify ...

The genetics company is closing a unit that was once seen as core to its future.

Recent advances in genetic testing technology have transformed personal health care from general guidelines to precise, ...

focusing instead on selling genetic tests to consumers and using the resulting data for research. In closing its therapeutics ...

Once millions used it to find out about their family histories - this week it was almost delisted. What went wrong?

Patients who have two variants in the gene will likely be much sicker, much faster. Drug authorities in the UK and European Union have recommended pre-treatment DPYD testing since 2020.

Google DeepMind releases AlphaFold 3's source code to academics, marking a significant advance in AI-powered molecular biology and drug discovery, while balancing open science with commercial ...

In closing its therapeutics division and laying off 200 people, 23andMe ended an audacious bet it made nearly a decade ago — ...

23andMe currently lists two assets in early-stage testing. First ... The dual-mechanism drug targets ULBP6, which is secreted ...

Ibuprofen counters problems caused by mutations in the MAN1B1 gene, fruit fly tests show. Early results in three children are ”fairly positive.” ...

23andMe is laying off 40% of its workforce, or more than 200 employees, and discontinuing its therapeutics division as the ...